A systematic framework for assessing the clinical impact of polygenic risk scores

Scott Kulm, Andrew Marderstein, Jason Mezey, Olivier Elemento
doi: https://doi.org/10.1101/2020.04.06.20055574

Article Information

doi 
https://doi.org/10.1101/2020.04.06.20055574
History 
  • March 8, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Scott Kulm1,2,3,
  2. Andrew Marderstein2,
  3. Jason Mezey4,5,* and
  4. Olivier Elemento2,3,*
  1. 1Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY
  2. 2Caryl and Israel Englander Institute of Precision Medicine, Weill Cornell Medicine, New York, NY
  3. 3Physiology, Biophysics and Systems Biology Graduate Program, Weill Cornell Medicine, New York, NY
  4. 4Department of Genetic Medicine, Weill Cornell Medicine, New York, NY
  5. 5Department of Computational Biology, Cornell University, Ithaca, NY
  1. ↵*corresponding authors; email: ole2001{at}med.cornell.edu
Back to top
Posted March 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A systematic framework for assessing the clinical impact of polygenic risk scores
Scott Kulm, Andrew Marderstein, Jason Mezey, Olivier Elemento
medRxiv 2020.04.06.20055574; doi: https://doi.org/10.1101/2020.04.06.20055574
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area